(19)
(11) EP 1 199 360 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
02.05.2002 Bulletin 2002/18

(43) Date of publication A2:
24.04.2002 Bulletin 2002/17

(21) Application number: 01127469.3

(22) Date of filing: 28.02.1997
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/715, C07K 16/28, G01N 33/50, G01N 33/53, C12Q 1/68
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 01.03.1996 EP 96870021
06.08.1996 EP 96870102

(62) Application number of the earlier application in accordance with Art. 76 EPC:
97904948.3 / 0883687

(71) Applicant: Euroscreen S.A.
1070 Brussels (BE)

(72) Inventors:
  • Samson, Michel
    35700 Rennes (FR)
  • Parmentier, Marc
    1604 Linkebeek (BE)
  • Vassart, Gilbert
    1200 Brussels (BE)
  • Libert, Frédérick
    1428 Braine-L'Alleud (BE)

(74) Representative: Van Malderen, Joelle et al
Office Van Malderen, Place Reine Fabiola 6/1
1083 Bruxelles
1083 Bruxelles (BE)

   


(54) Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor


(57) The present invention is related to new peptides and the nucleic acid molecules encoding said peptides.
The present invention concerns also the vector comprising said nucleic acid molecules, cells transformed by said vector, inhibitors directed against said peptides or said nucleic acid molecules, a pharmaceutical composition and a diagnostic and/or dosage device comprising said products, and non human transgenic animals expressing the peptides according to the invention or the nucleic acid molecules encoding said peptides.







Search report